A committed and highly accomplished biotechnology expert with 16 years of research and development experience, leading and supervising teams and managing a wide range
of drug development projects for small biotechnology companies.
Our long - term investment in this world class institution with more than 200 employees has opened invaluable opportunities for scientific exchange and cross-talk which, although not directly translated
into drug development projects, has greatly contributed to our research advances for more than 15 years.»
For the last several years LPS has worked
on drug development projects and drug design in close cooperation with a number of major players in the Polish BioTechMed industry; including Adamed and Oncoarendi.
Mundel's appointment likely reflects the Gates Foundation's desire to apply that approach to their health and
drug development projects, says Denise DeMan - Williams, founder and CEO of the biotech recruiting firm Bench International (who recruited Mundel for the Novartis job).
These drug development projects will be maturing in 2018, and would greatly benefit from input from the field.